Contemporary Hematology T-Cell Lymphomas 2013

Yale University School of Medicine

This volume presents up‑to‑date information on the biology and treatment of hematologic cancers, including adult T‑cell leukemia‑lymphoma, Hodgkin’s disease, and non‑Hodgkin’s lymphoma. It discusses novel agents such as gemcitabine, forodesine, and antithymocyte globulin, and evaluates outcomes of stem‑cell transplantation and reduced‑intensity conditioning regimens. The text also details response criteria, clinical trial data, and mechanistic insights into drug actions like ribonucleotide reductase inhibition. Authored by leading experts, it serves as a core resource for clinicians and trainees in hematology and oncology.